State of the Industry Report 2026

Background

It brings together developments across industry, ingredients and manufacturing, products and consumers, investment, science and technology, and policy and regulation. The report examines how the sector has evolved and identifies opportunities and challenges in bringing smart protein products and technologies to commercial scale. This resource is useful for businesses, investors, researchers, policymakers, and ecosystem enablers and it offers insights to inform decisions and identify opportunities for collaboration across the value chain.

Since GFI India’s first State of the Industry Report in 2023, India’s smart protein sector has navigated a more cautious investment environment while broadening its commercial focus. Business-to-business and food service channels, co-manufacturing, and domestic ingredient production have become increasingly important. During the same period, smart protein entered national and state policy agendas, while research expanded into indigenous crops, novel protein sources, nutrition, and scale-up challenges. These developments reflect the sector’s growing relevance to India’s priorities around nutrition, agricultural value-addition, domestic manufacturing, and resilient supply chains.

This edition examines the progress made and the work ahead: translating research into commercial technologies, improving access to suitable infrastructure and finance, and delivering products that meet consumer expectations on taste and price.

Key insights

Commercial activity is expanding beyond retail product launches.
Business-to-business and food service channels, co-manufacturing, and domestic ingredient production are becoming more prominent, creating opportunities across the smart protein value chain.
Capital is more selective, and manufacturing needs a broader financing mix.
Private investors are favouring companies with revenue and clearer paths to scale, while public funding and grants became a more meaningful part of India’s funding mix going forward. Capital-intensive manufacturing will require patient capital, blended finance, and alternative financing approaches.
Interest in protein and nutrition offers opportunities for smart protein.
India’s broader high-protein segment attracted more than 10 deals worth over ₹305 crore (~$35 million) in 2025. This interest in nutrition-focused products and high-value ingredients points to opportunities for smart protein companies within the wider protein market.
Research is increasingly aligned with industry needs.
Research expanded into indigenous crops, agricultural sidestreams, and novel protein sources, alongside work on nutrition and scale-up barriers. Turning these advances into commercial technologies and building practical industry skills remain priorities.
A stronger enabling environment is taking shape.
BioE3 and state policies have strengthened policy support for smart protein, alongside new research infrastructure and talent programmes. Clear regulatory pathways and access to facilities will be important in translating this progress into commercial production.
Domestic ingredients and equipment are central to scaling competitively.
India remains reliant on imports for plant protein isolates and specialised equipment. Expanding domestic production of functional ingredients and equipment can help reduce this dependence and support progress towards taste and price parity.